Poland vs Russian Federation: Share of S. aureus infections resistant to methicillin
Poland
13.7%
in 2022
Russian Federation
17.0%
in 2021
Poland rank
27th
Russian Federation rank
25th
Share of S. aureus infections resistant to methicillin over time
- Poland
- Russian Federation
How they compare
Russian Federation currently reports 17.0% against 13.7% in Poland, a difference of 3.3%.
That makes Russian Federation's figure about 1.2 times Poland's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Russian Federation ahead.
Poland ranks 27th and Russian Federation ranks 25th of 45 countries.
Russian Federation has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Poland | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.3% | 19.1% | 3.7% | Russian Federation |
| 2020s | 15.6% | 23.0% | 7.4% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Poland or Russian Federation?
- Russian Federation, at 17.0% against 13.7% in Poland as of 2021.
- What is the difference in share of s. aureus infections resistant to methicillin between Poland and Russian Federation?
- 3.3%, with Russian Federation ahead.
- How many years of comparable data are there for Poland and Russian Federation?
- 5 years are reported by both, from 2017 to 2021.
- How do Poland and Russian Federation rank globally for share of s. aureus infections resistant to methicillin?
- Poland ranks 27th and Russian Federation ranks 25th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).